Latest News of AMLX
Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
By Yahoo! Finance |
2 weeks ago
Camille L. Bedrosian, Chief Medical Officer, discussed the phase III trial design for PBH, emphasizing a 90 mg dose with primary endpoint of composite level II and III hypoglycemia. Data is expected i...
Amylyx Pharmaceuticals (AMLX): Leading Nano Cap in Neurodegenerative Disease Treatments
By Yahoo! Finance |
1 month ago
An analysis of the best nano cap stocks to invest in highlights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) as a top choice. The company focuses on developing treatments for neurodegenerative diseases...
Director Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
By Yahoo! Finance |
2 months ago
Amylyx Pharmaceuticals Inc focuses on developing treatments for neurodegenerative diseases. Recent insider buying by Karen Firestone reflects confidence in the company's future. Investors may consider...